Skip to main content
. 2022 Jul 8;94(1126):20210310. doi: 10.1259/bjr.20210310

Table 2.

Mean ± standard deviation of the median values obtained from the tumour volumes for responders and non-responders

MRI parameters Responders (n = 6) Non-responders (n = 4)
Visit 1 Visit 2 Post-RT visit Visit 1 Visit 2 Post-RT visit
ADC (x10-5 mm2/s) 229.3 ± 47.9 251.8 ± 24.3 238.6 ± 27.7 227.2 ± 27.7 246.2 ± 29.8 193.7 ± 51.8
T2a (ms) 163.6 ± 75.7 145.9 ± 86.4 58.0 ± 25.0 64.2 ± 54.8 63.7 ± 47.0 33.8 ± 17.9
(Gd) (a10–3 mmol ml−1) 0.5 ± 0.2a 0.42 ± 0.22 0.16 ± 0.13 0.09 ± 0.05a 0.14 ± 0.08 0.10 ± 0.03
IAUGC (mmol*s) 7.5 ± 3.0a 7.0 ± 5.0 3.7 ± 2.1 1.8 ± 1.1a 3.1 ± 0.9 3.3 ± 1.1
Ktrans (min-1) (adjusted to EF) 0.07 ± 0.02a 0.06 ± 0.04 0.04 ± 0.03 0.02 ± 0.01a 0.03 ± 0.01 0.03 ± 0.01
Volume (cc) 54.3 ± 40.8 43.3 ± 33.2 23.8 ± 19.7 64.7 ± 58.7 65.0 ± 60.0 40.5 ± 40.0
RECIST 1.1 response classificationb Partial response (n = 4)
Stable disease (n = 2)
Partial response (n = 1)
Stable disease (n = 3)

ADC, apparent diffusion coefficient; RT, radiotherapy.

Response classification according to RECIST 1.1 criteria. Number of patients considered for the calculations are clearly stated in the legend of Figure 3.

a

Denotes significant differences between responders and non-responders.

b

Please see Supplementary Table 1 for the RECIST 1.1 classification of all 10 patients separately.